Reviva Pharmaceuticals I...

0.56
-0.06 (-9.79%)
At close: Apr 02, 2025, 3:59 PM
0.59
4.82%
After-hours: Apr 02, 2025, 04:34 PM EDT

Reviva Pharmaceuticals Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a 724.74K n/a n/a
Gross Profit n/a n/a n/a -724.74K n/a n/a
Operating Income -39,503.6B -24.31M -10.1M -2.43M -376.86K -1.12M
Interest Income n/a 182.8K n/a 105.18K 201.00 n/a
Pretax Income -39.24M -24.32M -8.52M -3.78M -846.03K -1.68M
Net Income -39,260.8B -24.34M -8.52M -3.78M -846.83K -1.68M
Selling & General & Admin 8,083.8B 5.36M 5.25M 2.14M 181.12K 175.58K
Research & Development 31,419.8B 18.95M 4.85M 295.15K 195.74K 946.3K
Other Expenses n/a n/a n/a n/a n/a -0.00
Operating Expenses 39,503.6B 24.31M 10.1M 2.43M 376.86K 1.12M
Interest Expense n/a 182.8K 2.41K 1.45M 469.37K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses 39.5M 24.31M 10.1M 2.43M 376.86K 1.12M
Income Tax -16.95B 20.78K 6K 800.00 800.00 800.00
Shares Outstanding (Basic) 23.8M 19.52M 14.79M 3.06M 2.77M n/a
Shares Outstanding (Diluted) 23.8M 19.52M 14.79M 3.06M 2.77M n/a
EPS (Basic) -1.65 -1.25 -0.58 -1.24 -0.31 n/a
EPS (Diluted) -1.65 -1.25 -0.58 -1.24 -0.31 n/a
EBITDA -39,503.6B -24.11M -10.1M -2.33M -376.01K -1.12M
EBIT -39.24M n/a n/a n/a n/a -1.12M
Depreciation & Amortization n/a 194.71K 236.56K 105.77K 846.00 1.02K